Aspicio Therapeutics, Inc.

New Filing
CIK: 0002025735·Other Health Care·DELAWARE·Filed: Jul 17, 2026
Total Offering

$200,000

Amount Sold

$200,000

Investors

2

First Sale

Jul 16, 2026

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Michael Keane

Company

Aspicio Therapeutics, Inc.

250 TRUMAN WAY

DOWNINGTOWN, PA, 19335

484.885.4744

SEC Filing

0002025735-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Aspicio Therapeutics, Inc. Form D Filing — $200,000 | FilingFlow